Buy NAD+ injection and you are choosing between three formats that share one failure point. The IV bag, the subcutaneous vial and the clinic shot differ in convenience and cost, but all three stand or fall on whether the material going in was made to a sterile-injectable standard.
Key takeaways
- Three formats exist and they are not interchangeable purchases: a compounded IV bag administered in a clinic, a research vial of powder bought online, and a smaller shot given in a clinic room. Each puts the sterility burden in a different place.
- FDA has on record that compounders were using food-grade NAD+ from repackagers to make intravenous products, and that adverse event reports include severe chills, shaking, vomiting and fatigue consistent with excessive endotoxin levels.
- Endotoxin is not the same question as purity. A certificate reporting HPLC and mass spec confirms the powder is NAD+ and mostly NAD+, and says nothing about bacterial breakdown products. Ask for the bacterial endotoxin result specifically.
- The sterility bar is highest exactly where buying is most casual. A gram of powder ordered online carries the same requirement as a compounded bag, with none of the pharmacy controls behind it.
- For a lifter the cost of getting this wrong is not the price of the vial. An endotoxin reaction is a week of feeling flattened in the middle of a block, and that is the expensive part.
The vendor we point lifters to
NAD+ from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
Quoted per 100 mg because NAD+ is dosed in hundreds of milligrams, not the single milligrams a peptide vial holds. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 20, 2026.
Buy NAD+ injection: three formats, one shared requirement
The word injection is doing a lot of work in this search, because it covers products that arrive by completely different routes.
| Format | Where it comes from | What you are handed | Where sterility is controlled |
|---|---|---|---|
| Compounded IV infusion | A 503A or 503B compounding pharmacy, administered at a clinic | A prepared bag, infused under supervision during a booked appointment | The pharmacy, in theory, subject to the grade of the bulk material it started from |
| Research vial | An online supplier, shipped to you | Sealed powder labeled for laboratory use | The manufacturer of the bulk material, and nobody after that |
| Clinic shot | The same compounded supply chain, smaller volume | A prepared syringe given in the room | The pharmacy and the clinic |
The middle row is the one this site's readers actually use, and it is the row with the fewest controls between the bulk manufacturer and the person. That is not an argument that the clinic rows are safe by comparison. FDA's concern, as set out below, was specifically about the compounded route, which tells you that a professional setting does not automatically fix the input.
What matters across all three is upstream of the format. A bag, a vial and a syringe made from the same questionable batch of powder carry the same problem in three different containers.
What FDA actually found in the injectable NAD+ supply
This is the most useful paragraph on this page, and it is quoted rather than paraphrased because paraphrase softens it.
In a notice titled around ingredients suitable for sterile compounding, content current as of 10/30/2024, FDA stated that the agency "is aware of compounders using food-grade nicotinamide adenine dinucleotide (NAD+) sold by repackagers to make intravenous products." It continued: "Ingredients identified as food grade are not suitable for compounding sterile drugs without appropriate processing, due to the high risk of contamination with microbes and endotoxins, which can harm patients." And then the part that describes what that looks like in a person: "FDA has received adverse event reports following use of NAD+ injectable drugs, including severe chills, shaking, vomiting and fatigue with some requiring medical treatment. These reactions are consistent with excessive levels of endotoxins."
The notice is published on FDA's compounding pages and it also urges repackagers to label clearly when an ingredient is intended for food or dietary supplement use, so that compounders do not pick it up by mistake.
Read that carefully and the shape of the problem appears. NAD+ is a legitimate food and supplement ingredient. It is manufactured at that grade in volume, it is cheap, and it is chemically the same molecule as the pharmaceutical-grade material. What differs is the process controls, the environment it was made in, and above all the bacterial endotoxin load, which the food-grade specification is not written to keep low because nobody eating it will care.
Endotoxins are fragments of bacterial cell wall. They survive the sterilization that kills the bacteria themselves, which is why sterile is not the same as endotoxin-free. Swallowed, they are largely a non-event. Introduced into a vein, they produce exactly what FDA logged: rigors, shaking, vomiting, and a flattening fatigue.
Why the sterility bar is highest where buying is most casual
There is an inversion in this market that is worth stating directly.
The transaction with the most safeguards is the clinic infusion, which is also the one people agonize over most because it costs the most and involves a booking. The transaction with the fewest safeguards is a gram of powder ordered online in ninety seconds between sets, which people agonize over least because it costs $52.00 and arrives in a padded envelope.
The requirement does not scale with the price or the friction. If material is going into a person by any injectable route, it needs to have been made to a standard that keeps endotoxin low, and buying it casually does not lower the bar. It just removes everyone who would otherwise have checked.
This is the specific way NAD+ differs from the peptides covered elsewhere on this site. When someone goes to buy BPC-157 online, the main documented worry is whether the vial contains what the label says. With NAD+, identity is rarely the issue. The material almost certainly is NAD+. The issue is which grade of NAD+, and that question is invisible to every test that most vendors publish.
The NAD+ injection buy checklist, in the order that matters
Applied to a listing, the FDA notice converts into a small number of concrete asks. Order matters, because the first two decide whether the rest is worth reading.
- Grade. Does the listing or the certificate state pharmaceutical grade, and does it distinguish that from food grade? Silence on grade is an answer.
- Bacterial endotoxin result. Does the certificate of analysis report an endotoxin figure, typically from an LAL method, with a numeric result and a specification? Identity plus purity is not a substitute.
- Manufacturer versus repackager. Was the material made by the entity naming itself on the certificate, or bottled by it? FDA's notice was specifically about material moving through repackagers, and repackaging does not upgrade a grade.
- Batch specificity. Does the lot number on the certificate match the lot printed on the vial that arrived? A generic certificate for the product rather than the batch tells you about a batch you did not receive.
- Named third-party lab. Is the testing lab identified by name, with an address you can find? An in-house report is a claim about itself.
- Storage and expiry stated. Does the supplier state storage conditions and a retest or expiry date for the lot?
A supplier that answers the first two clearly has already separated itself from most of the market. The complete version of this framework, scored against the vendor above, is on NAD+ where to buy, and the ranking method that weights these criteria is on best NAD+ source.
Buy NAD+ IV: what the bag adds and what it does not
People searching to buy NAD+ IV usually mean one of two things: booking a clinic session, or acquiring the components to run something at home.
The first is a real, available service, and it is covered from the local-search angle on NAD+ near me. What you are buying there is a compounded sterile preparation plus supervision, and the questions to bring are the same ones above, redirected: ask which pharmacy compounds it, whether the bulk substance is pharmaceutical grade, and whether the pharmacy's release testing includes endotoxin. A clinic that can answer is a different proposition from one that looks blank.
The second is not something this article is going to help with, and the reason is not squeamishness. Intravenous administration outside a clinical setting adds failure modes that have nothing to do with the compound: air, contamination introduced at the point of access, volume and rate, and no one present if a reaction starts. FDA's adverse event reports describe people needing medical treatment while in a clinic. The same reaction with nobody in the room is a different event.
So this page states formats and criteria and stops there. No preparation steps, no volumes, no rates. If you are looking for how the arithmetic works on a gram of powder, that belongs to Peptide Dosage, which covers it at NAD+ dosage with the conversion tool at the NAD+ calculator.
What a bad batch actually costs a lifter
The financial downside of a poor NAD+ injection purchase is $52.00. That is not the number that should be driving the decision.
Read FDA's list again with a training calendar in mind: severe chills, shaking, vomiting and fatigue, some requiring medical treatment. A systemic inflammatory response of that kind takes appetite, sleep and the ability to produce force with it, and FDA notes that some of the reported cases required medical treatment. Dropped sessions, a deload nobody planned, and a stretch of eating badly during a phase that was supposed to be productive.
The irony is that the marketing pitch for NAD+ is aimed squarely at fatigue and flat sessions. The plausible downside of buying it badly is a much larger and much better documented version of exactly the problem it is sold to solve.
Which is worth holding next to the evidence picture. NAD+ is a coenzyme at the center of energy metabolism, and that biochemistry is not in dispute. The leap from that to an injection improving how a training block goes is marketing rather than a finished human efficacy trial, and the things that reliably do move work capacity across a block are unglamorous: managed weekly load, sleep, and energy availability. This site covers those in resistance training and myostatin and sleep, cortisol and myostatin.
Buying carefully does not make the evidence better. It just means that if you decide to buy anyway, the downside stays theoretical rather than showing up on a Tuesday.
Frequently asked questions
What is the difference between an NAD+ IV and an NAD+ injection?
An IV is a compounded preparation infused into a vein during a booked clinic appointment. An injection generally means a much smaller volume given subcutaneously or intramuscularly. The formats differ in volume, setting and how quickly the material enters circulation, but both require the same sterile-injectable standard on the material itself.
Why does everyone keep talking about endotoxins with NAD+?
Because FDA specifically flagged it. The agency reported compounders using food-grade NAD+ from repackagers for intravenous products, warned that food-grade ingredients carry a high risk of microbial and endotoxin contamination, and logged adverse event reports of severe chills, shaking, vomiting and fatigue consistent with excessive endotoxin levels.
Does a 99% purity certificate mean the NAD+ is safe to inject?
No. Purity by HPLC tells you what fraction of the powder is NAD+ rather than something else. Bacterial endotoxin is a separate assay measuring something a purity chromatogram does not see. A certificate without an endotoxin result has not answered the question that produced FDA's adverse event reports.
Is NAD+ sold online the same material clinics use?
Sometimes, and that is the problem rather than the reassurance. Compounding pharmacies buy bulk NAD+ too, and FDA's notice was about compounders receiving food-grade material from repackagers. Grade and testing scope decide it, not the channel, so the question is which grade and which certificate, whichever route the material took.
Can I buy an NAD+ shot without going to a clinic?
Research suppliers sell NAD+ powder online, labeled for laboratory use and not for human consumption, and that is the route most people end up on. It is not a prescription product and no supplier can lawfully sell it for injection into a person. Compounded NAD+ prepared for a named patient is a separate route that runs through a prescriber and a pharmacy, and it operates under an FDA interim policy that means non-enforcement pending evaluation rather than approval.
This article is for educational purposes only and is not medical advice. It contains no preparation, dosing or administration instructions. NAD+ is not an FDA-approved medicine, and material sold by research suppliers is labeled for laboratory use only and not for human consumption. Speak with a qualified healthcare professional before making any decision involving injections, infusions or unapproved compounds.